Author name: Aimee Ellam

We had a fantastic time at the 45th Annual Meeting of the American College of Toxicology (ACT 2024), held from 12 – 17th November in Austin, Texas. ACT’s annual meetings embody their mission to “Educate, Lead, and Serve” scientists by providing a forum for exchanging information and perspectives on safety assessment and applied toxicological sciences.

Nitrosamines, a class of chemical compounds known for their potential carcinogenic properties, have become a significant concern for the pharmaceutical industry. In line with revised guidance from the European Medicines Agency (EMA), regulatory agencies require N-nitrosamines risk assessments to be performed on all marketed medical products investigating nitrosamine formation potential and their mutagenic and carcinogenic